Biotechnology Bulletin ›› 2019, Vol. 35 ›› Issue (12): 64-75.doi: 10.13560/j.cnki.biotech.bull.1985.2019-0696
• Orginal Article • Previous Articles Next Articles
GENG Hui-jun1, ZOU Wei2, CUI Hui-jing1, LI Xiao-yu1, WANG Li-li1, XU Yong-ping1, 3
Received:
2019-08-02
Online:
2019-12-26
Published:
2019-12-03
GENG Hui-jun, ZOU Wei, CUI Hui-jing, LI Xiao-yu, WANG Li-li, XU Yong-ping. Safety Evaluation of Staphylococcus aureus Bacteriophage Based on Transcriptome[J]. Biotechnology Bulletin, 2019, 35(12): 64-75.
[1] d’Herelle F. Bacteriophage as a treatment in acute medical and surgical infections[J]. Bull N Y Acad Med, 1931, 7(5):329-348. [2] d’Herelle F. On an invisible microbe antagonistic toward dysenteric bacilli:brief note by Mr. F. D’Herelle, presented by Mr. Roux[J]. Research in Microbiology, 2007, 158(7):553-554. [3] Twort WF.An investigation on the nature of ultramicroscopic viruses[J]. Lancet, 1915, 186(4814):1241-1243. [4] Keen EC.Felix d’Herelle and our microbial future[J]. Future Microbiology, 2012(7):1337-1339. [5] Salmond GP, Fineran PC.A century of the phage:past, present and future[J]. Nature Reviews Microbiology, 2015, 13(12):777-786. [6] Biswajit B, Sankar A, Paul W, et al.Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium[J]. Infection & Immunity, 2002, 70(1):204-210. [7] Jamal M.Bacteriophages:an overview of the control strategies against multiple bacterial infections in different fields[J]. J Basic Microbiol, 2019, 59(2):123-133. [8] Hawkey PM, Jones AM.The changing epidemiology of resistance[J]. J Antimicrob Chemother, 2009, 64(S1):3-10. [9] Llanos CA, Citorik RJ, Nickerson KP, et al.Bacteriophage therapy testing against shigella flexneri in a novel human intestinal organoid-derived infection model[J]. Journal of Pediatric Gastroenterology and Nutrition, 2019, 68:509-516. [10] Krylov V, Shaburova O, Pleteneva E, et al.Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections[J]. Virologica Sinica, 2015, 30(1):33-44. [11] Lin DM, Koskella B, Lin HC.Phage therapy:An alternative to antibiotics in the age of multi-drug resistance[J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017, 8(3):162-173. [12] Jean-Paul P, Gilbert V, Pieter-Jan C, et al.The magistral phage[J]. Viruses, 2018, 10(2):64-71. [13] Doss J, Culbertson K, Hahn D, et al.A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms[J]. Viruses, 2017, 9(3):50-60. [14] Jennes S, Merabishvili M, Soentjens P, et al.Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report[J]. Critical Care, 2017, 21(1):129-131. [15] Dedrick RM, Guerrero-Bustamante CA, et al.Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus[J]. Nature Medicine, 2019, 25(5):730-733. [16] Quail MA, Kozarewa I, Smith F, et al.A large genome center’s improvements to the Illumina sequencing system[J]. Nature Methods, 2008, 5(12):1005-1010. [17] Geng HJ, Zou W, et al.Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice[J]. Folia Microbiol, 2019, DOI:10. 1007/s12223-019-00729-9. [18] 李跃. 金黄色葡萄球菌裂解性噬菌体治疗乳房炎的实验研究[D]. 长春:吉林大学, 2014. [19] Minsik K, Sangryeol R.Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli[J]. Applied & Environmental Microbiology, 2011, 77(6):2042-2050. [20] Bryan D, El-Shibiny A, Hobbs Z, et al.Bacteriophage T4 infection of stationary phase E. coli:life after log from a phage perspective[J]. Frontiers in Microbiology, 2016, 7(9):1391. [21] 张建城. 溶藻弧菌噬菌体特性及其防控刺参感染的研究[D]. 大连:大连理工大学, 2017. [22] Tuchscherr LP, Buzzola FR, Alvarez LP, et al.Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice[J]. Infection & Immunity, 2005, 73(12):7932-7937. [23] Schmeck B, Moog K, Zahlten J, et al.Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells[J]. Respiratory Research, 2006, 7(1):98. [24] 曲长庆, 邹伟, 张叶军. 一种制作高质量动物组织石蜡切片的方法[J]. 实验室科学, 2018, 21(2):75-78. [25] Robinson MD, Mccarthy DJ, Smyth GK. edgeR:a Bioconductor package for differential expression analysis of digital gene expression dat[J]. Bioinformatics, 2010, 26(1):139-140. [26] Anders SH, Huber W.Differential expression analysis for sequence count data[J]. Genome Biol, 2010, 11(10):R106. [27] Kendziorski NL.EBSeq:An R package for gene and isoform differential expression analysis of RNA-seq data[M], 2014. [28] Shujiro O, Takuji Y, Masami H, et al.KEGG Atlas mapping for global analysis of metabolic pathways[J]. Nucl Acids Res, 2008, 36(S2):423-426. [29] Bamford DH.Do viruses form lineages across different domains of life?[J]. Research in Microbiology, 2003, 154(4):231-236. [30] Weinbauer MG.Ecology of prokaryotic viruses[J]. FEMS Microbiology Reviews, 2010, 28(2):127-181. [31] Koen B, Ryan WH, Zachary H, et al.Efficacy and safety of a bovine-associated staphylococcus aureus phage cocktail in a murine model of mastitis[J]. Frontiers in Microbiology, 2017, 8:2348-2357. [32] Oliveira A, Sereno R, Nicolau A, et al.The influence of the mode of administration in the dissemination of three coliphages in chickens[J]. Poult Sci, 2009, 88(4):728-733. [33] Sulakvelidze A, Alavidze Z, Morris J.Bacteriophage therapy[J]. Antimicrobial Agents & Chemotherapy, 1934, 2(3858):1110-1113. [34] Uchiyama J, Maeda Y, Takemura I, et al.Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice[J]. Microbiology & Immunology, 2010, 53(5):301-304. [35] Bystricky V, Drahos V, Mulczyk M, et al.On the structure of some bacteriophages[J]. Acta Virologica, 1964, 8:369-372. [36] Inchley CJ.The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage[J]. Clinical & Experimental Immunology, 1969, 5(1):173-187. [37] Sulakvelidze A.Phage therapy:an attractive option for dealing with antibiotic-resistant bacterial infections[J]. Drug Discovery Today, 2005, 10(12):807-809. [38] Slopek S, Weber-Dabrowska B, Dabrowski M, et al.Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986[J]. Archivum Immunologiae Et Therapiae Experimentalis, 1987, 35(5):569-583. [39] Letarov AV, Golomidova AK, Tarasyan KK.Ecological basis for rational phage therapy[J]. Acta Naturae, 2010, 2(1):60-72. [40] Miedzybrodzki R, Switalajelen K, Fortuna W, et al.Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes[J]. Virus Research, 2008, 131(2):233-242. [41] Pajtaszpiasecka E, Rossowska J, Duś D, et al.Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma[J]. Immunology Letters, 2008, 116(1):24-32. [42] Lepage P, Colombet J, Marteau P, et al.Dysbiosis in inflammatory bowel disease:a role for bacteriophages?[J]. Gut, 2008, 57(3):424-425. [43] Fraser JS, Maxwell KL, Davidson AR.Immunoglobulin-like domains on bacteriophage:weapons of modest damage?[J]. Current Opinion in Microbiology, 2007, 10(4):382-387. [44] Letarov A, Manival X, Desplats C, et al.Gpwac of the T4-type bacteriophages:Structure, function, and evolution of a segmented coiled-coil protein that controls viral infectivity[J]. Journal of Bacteriology, 2005, 187(3):1055-1066. [45] Gallet R, Shao Y, Wang IN.High adsorption rate is detrimental to bacteriophage fitness in a biofilm-like environment[J]. BMC Evolutionary Biology, 2009, 9(1):241-250. [46] Mertz L.Battling superbugs:how phage therapy went from obscure to promising[J]. IEEE Pulse, 2019, 10(1):3-9. [47] Mya B, Chelsea B, Kema M, et al.Phage puppet masters of the marine microbial realm[J]. Nature Microbiology, 2018, 3(6):754-766. [48] Örmälä AM, Jalasvuori M.Phage therapy:Should bacterial resistance to phages be a concern, even in the long run?[J]. Bacteriophage, 2013, 3(1):214-219. [49] Loc-Carrillo C, Abedon ST.Pros and cons of phage therapy[J]. Bacteriophage, 2011, 1(2):111-114. [50] Mölling K.Viren statt antibiotika(in German)[J]. Spektrum der Wissenschaft, 2017, 10(17):42-49. [51] Reindel R, Fiore CR.Phage therapy:considerations and challenges for development[J]. Clinical Infectious Diseases, 2017, 64(11):1589-1590. [52] Hagens S, Habel A, von Ahsen U, et al. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage[J]. Antimicrobial Agents & Chemotherapy, 2004, 48(10):3817-3822. [53] Dufour N, Delattre RL, Ricard J, et al.The lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by β-Lactams[J]. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America, 2017, 64(11):1582-1588. [54] Speck P, Smithyman A.Safety and efficacy of phage therapy via the intravenous route[J]. FEMS Microbiology Letters, 2015, 363(3):242-247. [55] Broecker KM, Willy AC.A wake-up call:we need phage therapy now[J]. Viruses, 2018, 10(12):688-702. [56] Chan BK, Sistrom M, Wertz JE, et al.Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa[J]. Scientific Reports, 2016, 6:267-271. [57] Chaudhry WN, Concepción-Acevedo J, Park T, et al.Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms[J]. PLoS One, 2017, 12(1):e168615. [58] Andrzej G, Ryszard M, Jan B, et al.Bacteriophage therapy for the treatment of infections[J]. Current Opinion in Investigational Drugs, 2009, 10(8):766-774. [59] O’Flaherty S, Ross RP, Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria[J]. FEMS Microbiology Reviews, 2010, 33(4):801-819. |
[1] | XIONG He-li, SHA Qian, LIU Shao-na, XIANG De-cai, ZHANG Bin, ZHAO Zhi-yong. Application of Single-cell Transcriptome Sequencing in Animals [J]. Biotechnology Bulletin, 2022, 38(3): 226-233. |
[2] | KOU Jia-yi, WANG Yu-ling, ZENG Rui-lin, LAN Dao-liang. Application of Single-cell Transcriptome Sequencing in Mammalian [J]. Biotechnology Bulletin, 2022, 38(11): 41-48. |
[3] | CHEN Jian-jun, ZHAO Yi-di, CAO Xiang-lin. Comprehensive Transcriptome Analysis of Intestinal Epithelial Cells of Cyprinus carpio Exposed to Lipopolysaccharide [J]. Biotechnology Bulletin, 2021, 37(8): 213-220. |
[4] | ZHANG Jing, XIONG Yan, HUA Yong-lin, GUO Yu, XIONG Xian-rong, ZI Xiang-dong, LI Jian. Screening of Reference Genes for Quantitative PCR of Skeletal Muscle Fiber Types in Mice [J]. Biotechnology Bulletin, 2021, 37(2): 71-79. |
[5] | MA Yan-jun, DUAN Hui-rong, WEI Jia, RICHARD John Tiika, SHAN Li-shan, MA Rui. Transcriptome Sequencing Analysis of Lycium ruthenicum Murr. Under NaCl Stress [J]. Biotechnology Bulletin, 2020, 36(2): 100-109. |
[6] | ZHAO Yang-yang, GUO Yu-xiao, ZHANG Ling-yun. Transcriptome Sequencing and Analysis of Xanthoceras sorbifolia Bunge Fruit [J]. Biotechnology Bulletin, 2019, 35(6): 24-31. |
[7] | ZHANG Zhao-yang, PANG Jun-ling, HAN Mei, LENG Peng-fei, ZHAO Jun. Characterization of the Salt Tolerance of Transgenic Maize Line Expressing ABP9 [J]. Biotechnology Bulletin, 2019, 35(5): 48-57. |
[8] | WANG Yue-qiang, Avinash Bhandoola. Gene Editing in Mouse Lin-Sca1+Kit+ and Double Negative(DN)Primary Cell [J]. Biotechnology Bulletin, 2018, 34(5): 64-70. |
[9] | ZHANG Xue, CHEN Liang-liang, DAI Hong-xia, ZHANG Wen-sheng, REN Wen-yan. Functional Study of miR-22 in Mouse Embryonic Stem Cell with CRISPR/Cas9 System [J]. Biotechnology Bulletin, 2018, 34(5): 71-79. |
[10] | YUAN Bai-yin, LIU Zhong-ying. Optimization of EDU Pulse Method for Tracing the Migration of Mouse Second Heart Field Cells [J]. Biotechnology Bulletin, 2018, 34(12): 84-89. |
[11] | YUAN Bai-yin, HU Ji-sheng, LIU Zhong-ying, HUANG Xia. Wdr1 Knockout Inhibits Migration and Proliferation of Mouse Primary Vascular Smooth Muscle Cells [J]. Biotechnology Bulletin, 2018, 34(12): 179-185. |
[12] | LIU Si-jia, TIAN Fei, ZHANG Cun-fang, QIAO Zhi-gang, ZHAO Kai. Transcriptome Sequencing and Analysis of Hepatopancreas from Carps Under Cold Stress [J]. Biotechnology Bulletin, 2018, 34(11): 168-178. |
[13] | LIU Wen-rong ,DING Ruo-fan, ZHANG Yi-ming ,LI Yu-peng, LI Ling ,GUO Zhi-yun. Transcriptome Sequencing Analysis of Hepatocellular Carcinoma HepG2 Cells Induced by Antitumor Peptide 9R-P201 [J]. Biotechnology Bulletin, 2017, 33(7): 210-215. |
[14] | LUO Yan,LIU Xiao-gang,ZHOU Zhi-qin. Research Progress on Methods for Isolating the Gene of Plant Glycosyltransferase,and Its Biological Functions [J]. Biotechnology Bulletin, 2016, 32(12): 34-39. |
[15] | Meng Beiqian, Zhang Huiwen, Zhang Guojun, Xu Mingkai, Li Xu, Zhang Chenggong. Comparison of the Superantigen Sensitivity on Staphylococcal Enterotoxins C2 in Guinea Pigs and BALB/c Mice [J]. Biotechnology Bulletin, 2015, 31(9): 224-231. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||